OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 121.2% based on the discounted cash flow analysis.
| Market cap | $7.54 Billion |
|---|---|
| Enterprise Value | $3.17 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.34 |
| Outstanding Shares | 298,184,000 |
| P/E Ratio | -76.58 |
|---|---|
| PEG | -52.21 |
| Price to Sales | 0.66 |
| Price to Book Ratio | 5.78 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | 184.65 |
| Enterprise Value to Net Income | -81 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.26 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 107.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.16%▼ 57.35% |
|---|---|
| Total Invested | $99.12M▼ 95.06% |
| Investors Holding | 39▼ 326.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...